Clinical Trial Update: Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial evaluating adebrelimab in combination with chemotherapy for esophageal squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: The Second Hospital of Shandong University | Conditions: Pathological Complete Remission, Objective Response Rate | NA | Status: RECRUITING